Table 3 Human cancer-associated lncRNAs

HOTAIR

2158 nt

12q13.13

Breast

[18, 68]

MALAT1/α/NEAT2

7.5 kb

11q13.1

Breast, lung, uterus, pancreas, colon, prostate, liver, cervix¹, neuroblastoma¹, osteosarcoma

[135, 137–139, 152, 255, 256]

HULC

500 nt

6p24.3

Liver, hepatic colorectal metastasis

[170, 171]

BC200

200 nt

2p21

Breast, cervix, esophagus, lung, ovary, parotid, tongue

[50, 51]

H19

2.3 kb

11p15.5

Bladder, lung, liver, breast, endometrial, cervix, esophagus, ovary, prostate, choricarcinoma, colorectal

[74, 92, 95, 97, 102, 103, 257–264]

BIC/MIRHG155/MIRHG2

1.6 kb

21q11.2

B-cell lymphoma

[153]

PRNCR1

13 kb

8q24.2

Prostate

[187]

LOC285194

2105 nt

3q13.31

Osteosarcoma

[265]

PCGEM1

1643 nt

2q32.2

Prostate

[188, 266, 267]

UCA1/CUDR

1.4 kb, 2.2 kb, 2.7 kb

19p13.12

Bladder, colon, cervix, lung, thyroid, liver, breast, esophagus, stomach

[268–270]

DD3/PCA3

0.6 kb, 2 kb, 4 kb

9q21.22

Prostate

[189, 190]

anti-NOS2A

~1.9 kb

17q23.2

Brain¹

[271]

uc.73A

201 nt

2q22.3

Colon

[200]

TUC338 (encodes uc.338)

590 nt

12q13.13

Liver

[203]

ANRIL/p15AS/CDK2BAS

34.8 kb & splice variants

9p21.3

Prostate, leukemia

[175, 176, 183, 272]

MEG3

1.6 kb & splicing isoforms

14q32.2

Brain (downregulated)

[156–158, 162]

GAS5/SNHG2

Multiple isoforms

1q25.1

Breast (downregulated)

[273]

SRA-1/SRA (bifunctional)

1965 nt

5q31.3

Breast, uterus, ovary (hormone responsive tissue)

[274, 275]

PTENP1

~3.9 kb

9p13.3

Prostate

[173, 174]

ncRAN

2186 nt, 2087 nt

17q25.1

Bladder, neuroblastoma

[276, 277]